LNTH-2501/EVG-001

About Lantheus Medical Imaging

Lantheus Medical Imaging is an established, publicly traded radiopharmaceutical company with a robust commercial portfolio and a deep pipeline targeting oncology and neurology. Its strategy is built on a dual focus of commercializing novel diagnostic imaging agents and advancing a pipeline of targeted radiotherapeutics and diagnostics. With recent FDA approvals and a diverse clinical-stage portfolio, Lantheus is positioned at the forefront of the growing precision nuclear medicine market. The company faces competition and development risks but benefits from a strong commercial infrastructure and strategic partnerships.

Therapeutic Areas